Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Publications indexed to the term Hematologic Diseases

FacultyTitle
1Hematological and infectious complications with CD38 antigen targeting monoclonal antibody-based therapies in multiple myeloma: A meta-analysis of randomized control trials. (Yarlagadda N, Gundarlapalli S, Sharma S, Suelzer E, Abid MB, Abdallah AO, Schinke C, Atrash S, Mohan M) Leuk Res 2021 11;110:106714    
8Molecular mechanics and dynamic simulations of well-known Kabuki syndrome-associated KDM6A variants reveal putative mechanisms of dysfunction. (Chi YI, Stodola TJ, De Assuncao TM, Leverence EN, Tripathi S, Dsouza NR, Mathison AJ, Basel DG, Volkman BF, Smith BC, Lomberk G, Zimmermann MT, Urrutia R) Orphanet J Rare Dis 2021 02 05;16(1):66       3 Citations
1Limitations of Applying the Hematopoietic Cell Transplantation Comorbidity Index in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation. (Broglie L, Ruiz J, Jin Z, Kahn JM, Bhatia M, George D, Garvin J, Satwani P) Transplant Cell Ther 2021 01;27(1):74.e1-74.e9       1 Citation
1COVID-19 disease in New York City pediatric hematology and oncology patients. (Gampel B, Troullioud Lucas AG, Broglie L, Gartrell-Corrado RD, Lee MT, Levine J, Orjuela-Grimm M, Satwani P, Glade-Bender J, Roberts SS) Pediatr Blood Cancer 2020 09;67(9):e28420       21 Citations
1Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network. (Levine JE, Antin JH, Allen CE, Burroughs LM, Cooke KR, Devine S, Heslop H, Nakamura R, Talano JA, Yanik G, DiFronzo N) Biol Blood Marrow Transplant 2020 05;26(5):e94-e100       1 Citation
1Testicular tissue cryopreservation: 8 years of experience from a coordinated network of academic centers. (Valli-Pulaski H, Peters KA, Gassei K, Steimer SR, Sukhwani M, Hermann BP, Dwomor L, David S, Fayomi AP, Munyoki SK, Chu T, Chaudhry R, Cannon GM, Fox PJ, Jaffe TM, Sanfilippo JS, Menke MN, Lunenfeld E, Abofoul-Azab M, Sender LS, Messina J, Klimpel LM, Gosiengfiao Y, Rowell EE, Hsieh MH, Granberg CF, Reddy PP, Sandlow JI, Huleihel M, Orwig KE) Hum Reprod 2019 06 04;34(6):966-977       40 Citations
2Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors. (Majhail NS, Murphy E, Laud P, Preussler JM, Denzen EM, Abetti B, Adams A, Besser R, Burns LJ, Cerny J, Drexler R, Hahn T, Idossa L, Jahagirdar B, Kamani N, Loren A, Mattila D, McGuirk J, Moore H, Reynolds J, Saber W, Salazar L, Schatz B, Stiff P, Wingard JR, Syrjala KL, Baker KS) Haematologica 2019 05;104(5):1084-1092       24 Citations
1Limitations of poor bone marrow aspirations (for an accurate diagnosis) despite the multimodal analytical era: A longitudinal retrospective study. (Astle JM, Xu ML, Friedman T, Brown E) Am J Hematol 2017 Oct;92(10):E600-E602       2 Citations
1The impact of the UGT1A1*60 allele on bilirubin serum concentrations. (Pasternak AL, Crews KR, Caudle KE, Smith C, Pei D, Cheng C, Broeckel U, Gaur AH, Hankins J, Relling MV, Haidar CE) Pharmacogenomics 2017 Jan;18(1):5-16       3 Citations
1Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps. (Iotchkova V, Huang J, Morris JA, Jain D, Barbieri C, Walter K, Min JL, Chen L, Astle W, Cocca M, Deelen P, Elding H, Farmaki AE, Franklin CS, Franberg M, Gaunt TR, Hofman A, Jiang T, Kleber ME, Lachance G, Luan J, Malerba G, Matchan A, Mead D, Memari Y, Ntalla I, Panoutsopoulou K, Pazoki R, Perry JRB, Rivadeneira F, Sabater-Lleal M, Sennblad B, Shin SY, Southam L, Traglia M, van Dijk F, van Leeuwen EM, Zaza G, Zhang W, UK10K Consortium, Amin N, Butterworth A, Chambers JC, Dedoussis G, Dehghan A, Franco OH, Franke L, Frontini M, Gambaro G, Gasparini P, Hamsten A, Issacs A, Kooner JS, Kooperberg C, Langenberg C, Marz W, Scott RA, Swertz MA, Toniolo D, Uitterlinden AG, van Duijn CM, Watkins H, Zeggini E, Maurano MT, Timpson NJ, Reiner AP, Auer PL, Soranzo N) Nat Genet 2016 11;48(11):1303-1312       45 Citations
1Changing Trends of Unrelated Umbilical Cord Blood Transplantation for Hematologic Diseases in Patients Older than Fifty Years: A Eurocord-Center for International Blood and Marrow Transplant Research Survey. (Rafii H, Ruggeri A, Volt F, Brunstein CG, Carreras J, Eapen M, Gluckman E, Weisdorf DJ) Biol Blood Marrow Transplant 2016 09;22(9):1717-1720       7 Citations
1Safety of Living Donation of Hematopoietic Stem Cells. (Szer J, Elmoazzen H, Fechter M, Hwang W, Korhonen M, Miller J, Mengling T, Shaw B, Stein J) Transplantation 2016 06;100(6):1329-31       5 Citations
1Megakaryocyte- and megakaryocyte precursor-related gene therapies. (Wilcox DA) Blood 2016 Mar 10;127(10):1260-8       9 Citations
1Unrelated Cord Blood Transplantation in adults: evolution, experience and long-term outcomes in the UK National Health Service : a retrospective analysis on behalf of the British Society of Blood and Marrow Transplantation and Eurocord. (Snowden JA, Danby R, Ruggeri A, Marks DI, Hough RE, Pagliuca A, Potter M, Russell N, Craddock C, Clark A, Miller P, Cook G, Gluckman E, Shaw BE, Rocha V) Br J Haematol 2016 Feb;172(3):478-81       1 Citation
1Team-based learning on a third-year pediatric clerkship improves NBME subject exam blood disorder scores. (Saudek K, Treat R) Med Educ Online 2015;20:29021       8 Citations
1Double umbilical cord blood transplantation after novel myeloablative conditioning using a regimen of fludarabine, busulfan, and total lymphoid irradiation. (Abedin S, Peres E, Levine JE, Choi S, Yanik G, Couriel DR) Biol Blood Marrow Transplant 2014 Dec;20(12):2062-6       7 Citations
1[Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation]. (Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplantation Society of Australia and New Zeland (BMTSANZ), East Mediterrnean Blood and Marrow Transplantation Group (EMBMT), Sociedale Brasileira de Transplante de Medula Ossea (SBTMO)) Rinsho Ketsueki 2014 Jun;55(6):607-32       6 Citations
1The ASH Choosing Wisely®campaign: five hematologic tests and treatments to question. (Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA) Hematology Am Soc Hematol Educ Program 2013;2013:9-14       26 Citations
1Imputation of exome sequence variants into population- based samples and blood-cell-trait-associated loci in African Americans: NHLBI GO Exome Sequencing Project. (Auer PL, Johnsen JM, Johnson AD, Logsdon BA, Lange LA, Nalls MA, Zhang G, Franceschini N, Fox K, Lange EM, Rich SS, O'Donnell CJ, Jackson RD, Wallace RB, Chen Z, Graubert TA, Wilson JG, Tang H, Lettre G, Reiner AP, Ganesh SK, Li Y) Am J Hum Genet 2012 Nov 02;91(5):794-808       88 Citations
2Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. (Horan J, Wang T, Haagenson M, Spellman SR, Dehn J, Eapen M, Frangoul H, Gupta V, Hale GA, Hurley CK, Marino S, Oudshoorn M, Reddy V, Shaw P, Lee SJ, Woolfrey A) Blood 2012 Oct 04;120(14):2918-24       84 Citations
1Congenital corneal staphyloma as a complication of Kabuki syndrome. (Tanaka R, Takenouchi T, Uchida K, Sato T, Fukushima H, Yoshihashi H, Takahashi T, Tsubota K, Kosaki K) Am J Med Genet A 2012 Aug;158A(8):2000-2       10 Citations
1VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study. (Chang JE, Peterson C, Choi S, Eickhoff JC, Kim K, Yang DT, Gilbert LA, Rogers ES, Werndli JE, Huie MS, McFarland TA, Volk M, Blank J, Callander NS, Longo WL, Kahl BS) Br J Haematol 2011 Oct;155(2):190-7       49 Citations
3Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. (Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Horowitz MM, Bolwell B, Rizzo JD, Socié G) J Clin Oncol 2011 Jun 01;29(16):2230-9       397 Citations
1Graft-versus-host disease treatment: predictors of survival. (Levine JE, Logan B, Wu J, Alousi AM, Ho V, Bolaños-Meade J, Weisdorf D, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2010 Dec;16(12):1693-9       68 Citations
22010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. (Pasquini MC, Wang Z, Horowitz MM, Gale RP) Clin Transpl 2010:87-105       129 Citations
1Hematological issues in critically ill patients with cancer. (Carlson KS, DeSancho MT) Crit Care Clin 2010 Jan;26(1):107-32       15 Citations
1Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research. (Gupta V, Tomblyn M, Pedersen TL, Atkins HL, Battiwalla M, Gress RE, Pollack MS, Storek J, Thompson JC, Tiberghien P, Young JA, Ribaud P, Horowitz MM, Keating A) Biol Blood Marrow Transplant 2009 Jul;15(7):864-71       46 Citations
1Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. (Shaw BE, Veys P, Pagliuca A, Addada J, Cook G, Craddock CF, Gennery AR, Goldman J, Mackinnon S, Madrigal JA, Marks DI, Navarrete C, Potter MN, Querol S, Regan F, Russell NH, Hough RE) Bone Marrow Transplant 2009 Jul;44(1):7-12       12 Citations
1Granulocyte colony-stimulating factor administration: adverse events. (D'Souza A, Jaiyesimi I, Trainor L, Venuturumili P) Transfus Med Rev 2008 Oct;22(4):280-90       70 Citations
1Principles and analysis of hematopoietic stem cell transplantation outcomes: the physician's perspective. (Eapen M, Rocha V) Lifetime Data Anal 2008 Dec;14(4):379-88       7 Citations
1A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer. (LoConte NK, Thomas JP, Alberti D, Heideman J, Binger K, Marnocha R, Utecht K, Geiger P, Eickhoff J, Wilding G, Kolesar J) Cancer Chemother Pharmacol 2008 Dec;63(1):109-15       18 Citations
3The application of microarray analysis to pediatric diseases. (Hessner MJ, Liang M, Kwitek AE) Pediatr Clin North Am 2006 Aug;53(4):579-90       2 Citations
5BN phenome: detailed characterization of the cardiovascular, renal, and pulmonary systems of the sequenced rat. (Kwitek AE, Jacob HJ, Baker JE, Dwinell MR, Forster HV, Greene AS, Kunert MP, Lombard JH, Mattson DL, Pritchard KA Jr, Roman RJ, Tonellato PJ, Cowley AW Jr) Physiol Genomics 2006 Apr 13;25(2):303-13       28 Citations
1Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation. (Stiff PJ, Miller LA, Mumby P, Kiley K, Batiste R, Porter N, Potocki K, Volle M, Lichtenstein S, Wojtowicz S, Zakrzewski S, Toor A, Rodriguez T) Bone Marrow Transplant 2006 Mar;37(5):479-84       16 Citations
1Physiogenomic resources for rat models of heart, lung and blood disorders. (Malek RL, Wang HY, Kwitek AE, Greene AS, Bhagabati N, Borchardt G, Cahill L, Currier T, Frank B, Fu X, Hasinoff M, Howe E, Letwin N, Luu TV, Saeed A, Sajadi H, Salzberg SL, Sultana R, Thiagarajan M, Tsai J, Veratti K, White J, Quackenbush J, Jacob HJ, Lee NH) Nat Genet 2006 Feb;38(2):234-9       44 Citations
1Role of flow cytometry in pediatric hematopathology. (Kroft SH) Am J Clin Pathol 2004 Dec;122 Suppl:S19-32       21 Citations
2Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders. (Abed N, Casper JT, Camitta BM, Margolis D, Trost B, Orentas R, Chang CC) Bone Marrow Transplant 2004 Feb;33(3):321-7       13 Citations
1Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations. (Pullarkat VA, Bueso-Ramos C, Lai R, Kroft S, Wilson CS, Pullarkat ST, Bu X, Thein M, Lee M, Brynes RK) Am J Hematol 2003 May;73(1):12-7       73 Citations
1Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: a prospective longitudinal study. (Kupst MJ, Penati B, Debban B, Camitta B, Pietryga D, Margolis D, Murray K, Casper J) Bone Marrow Transplant 2002 Nov;30(9):609-17       60 Citations
1Perioperative assessment of coagulability in neurosurgical patients using thromboelastography. (Abrahams JM, Torchia MB, McGarvey M, Putt M, Baranov D, Sinson GP) Surg Neurol 2002 Jul;58(1):5-11; discussion 11-2       33 Citations
2Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. (Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaerts MA, Goldman J, Champlin RE, Keating A, Weisdorf DJ, de Witte TM, Horowitz MM) Blood 2002 Sep 15;100(6):1997-2004       234 Citations
1A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. (Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE) J Pediatr 2001 Dec;139(6):790-6       135 Citations
1Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose. (Keever-Taylor CA, Klein JP, Eastwood D, Bredeson C, Margolis DA, Burns WH, Vesole DH) Bone Marrow Transplant 2001 Apr;27(8):791-800       21 Citations
1Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia. (Vidarsson B, Abonour R, Williams EC, Woodson RD, Turman NJ, Kim K, Mosher DF, Wiersma SR, Longo WL) Leuk Lymphoma 2001 Apr;41(3-4):321-31       18 Citations
1Solid cancers after bone marrow transplantation. (Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socíe G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr) N Engl J Med 1997 Mar 27;336(13):897-904       742 Citations
1Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid. (Estey E, Thall PF, Mehta K, Rosenblum M, Brewer T Jr, Simmons V, Cabanillas F, Kurzrock R, Lopez-Berestein G) Blood 1996 May 01;87(9):3650-4       66 Citations
1Mucocutaneous paraneoplastic manifestations of hematologic malignancies. (Kurzrock R, Cohen PR) Am J Med 1995 Aug;99(2):207-16       67 Citations
1Bone marrow transplant nephropathy: radiation nephritis revisited. (Cohen EP, Lawton CA, Moulder JE) Nephron 1995;70(2):217-22       86 Citations
1Cytokines in tumor therapy. Interleukin-3. (Kurzrock R, Estrov Z, Talpaz M, Gutterman JU) Am J Clin Oncol 1991;14 Suppl 1:S45-50       8 Citations
1Tendency to serious sequelae of infection with the human immunodeficiency virus in sibships with hemophilia. (Meropol NJ, Krause PR, Ratnoff OD, Eyster ME, Levine PH, White GC, Debanne S, Rowland D, Lederman MM) Arch Intern Med 1989 Apr;149(4):885-8       3 Citations
1Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemia. (Quesada JR, Alexanian R, Kurzrock R, Barlogie B, Saks S, Gutterman JU) Am J Hematol 1988 Sep;29(1):1-4       53 Citations
1Episodic abnormalities in transcutaneous oxygen (TcPO2) recorded during neonatal intensive care. (Horbar JD, Soll RF, McAuliffe TL, Clark T, Lucey JF) J Perinatol 1987;7(1):2-7    
1Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients. (Kurzrock R, Rosenblum MG, Quesada JR, Sherwin SA, Itri LM, Gutterman JU) J Clin Oncol 1986 Nov;4(11):1677-83       41 Citations
1Clinical toxicity of interferons in cancer patients: a review. (Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU) J Clin Oncol 1986 Feb;4(2):234-43       563 Citations
1Oncologic emergencies II. Hematologic and infectious complications of cancer and cancer treatment. (Allegretta GJ, Weisman SJ, Altman AJ) Pediatr Clin North Am 1985 Jun;32(3):613-24       13 Citations
1Modification of gastrointestinal symptoms following irradiation by low dose rate technique. (Cassady JR, Order S, Camitta B, Marck A) Int J Radiat Oncol Biol Phys 1975 Oct-Nov;1(1-2):15-20       15 Citations